Invitae to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

SAN FRANCISCO--(BUSINESS WIRE)-- Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company’s management team will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Thursday, May 12, 2016 at approximately 8:00 a.m. Pacific in Las Vegas.

The live, listen-only webcast of the presentation may be accessed by visiting the Investors section of the company’s website at ir.invitae.com. A replay of the webcasts will be available shortly after the conclusion of the presentation and will be archived on the company’s website.

About Invitae

Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. For more information, visit our website at ir.invitae.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160428005210/en/

Invitae Corporation
Laura D’Angelo, 314-920-0617
[email protected]

Source: Invitae Corporation

You May Also Be Interested In

• Labcorp Announces Winning Bid for Select Assets of Invitae
• InVitae (NVTA) Enters into Agreement with Labcorp (LH) for Sale of Business
• ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC